Cleared Traditional

LD1 ISOENZYME REAGENT KIT (K890996) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K890996 · Trace Scientific , Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1989
Decision
67d
Days
Class 2
Risk

K890996 is an FDA 510(k) clearance for the LD1 ISOENZYME REAGENT KIT. Classified as Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes (product code JGF), Class II - Special Controls.

Submitted by Trace Scientific , Ltd. (Clayton, Vic 3168, AU). The FDA issued a Cleared decision on May 5, 1989 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1445 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Trace Scientific , Ltd. devices

Submission Details

510(k) Number K890996 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 1989
Decision Date May 05, 1989
Days to Decision 67 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 88d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JGF Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1445
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGF Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes

Devices cleared under the same product code (JGF) and FDA review panel - the closest regulatory comparables to K890996.
LD-1
K981338 · Abbott Laboratories · May 1998
ABBOTT QUICKSTART LD-1, MODIFICATION
K925188 · Em Diagnostic Systems, Inc. · Feb 1993
ABBOTT QUICKSTART LD-1,#5A30
K914261 · Em Diagnostic Systems, Inc. · Oct 1991
ABBOTT A-GENT LD-1 ISOZYME REAGENT
K871240 · Abbott Laboratories · May 1987